Related by context. Frequent words. (Click for all words.) 73 Options Trader Alert 72 Posts Large Volume Increase 71 Downside Target 71 Options Activity 70 #/#/# PriceWatch Alert Targets [002] 70 Interesting Options Volume 70 Bullish Engulfing Pattern 69 Q2 Loss Narrows 69 Q3 Loss Narrows 69 THE TREND CONTINUES DOWN 69 BREAKS THROUGH RESISTANCE AT 69 Downtrend Spotted 69 Posts Large 69 Showing Bullish 68 PriceWatch Alert Up 68 Q4 Loss Narrows 68 THE TREND CONTINUES UP 68 Q2 Loss Widens 68 PriceWatch Alert Targets 68 THE TREND CONTINUES LOWER 68 #/#/# PriceWatch Alert Targets [001] 68 APPROACHES NEW DOWNSIDE TARGET 67 Guides FY# Quick Facts 67 Bearish Harami Pattern 67 Looks Bullish 67 Q4 Loss Widens 67 WEEK HIGH RECENTLY ECLIPSED 67 Q3 Loss Widens 67 THE TREND CONTINUES HIGHER 67 SMARTREND DETECTS CONTINUED SELLING 66 BULLISH MOVING AVERAGE CROSSOVER 66 Bullish Harami Pattern 66 Skymark Research Initiates Independent 66 UPWARD MOMENTUM LOOKS TO 66 Analyst Expectations 66 quotes/comstock/# * 66 Annual Meeting Date 66 DOWNTREND SPOTTED IN SHARES 66 UPTREND SPOTTED IN SHARES 66 LOOKS TO CONTINUE TO 65 Lowers Guidance 65 Uptrend Spotted 65 Unusual Trading 65 WATCH FOR CONTINUED GAINS 65 Sees Continued Downward Momentum 65 SET TO POSSIBLY PULLBACK 65 SMARTREND DETECTS CONTINUED BUYING 65 Forecast Quick Facts 65 Rexahn Pharmaceuticals 65 PULLBACK IN SHARES OF 65 SHARES COULD POTENTIALLY PULLBACK 65 OFFERS INVESTORS BETTER VALUE 65 #.# Breakeven 65 PRXL 65 INCY 65 Guides Q3 65 OUT IN SHARES 65 See Continued Downward 65 SEES CONTINUED UPWARD MOMENTUM 64 Bearish Technical 64 Inc. NasdaqGM 64 Bearish Engulfing Pattern 64 Beats Analyst 64 Downgrade Alert Watch 64 Guides Q1 64 Guides Q4 64 Anadys Pharmaceuticals 64 Announces Share Repurchase 64 Rexahn Pharmaceuticals Inc. 64 Host Third Quarter 64 PROFILE CO 64 SEE CONTINUED UPWARD MOMENTUM 64 NASDAQ CRXL 64 Upgrade Alert 64 Q1 Profit Declines 63 TO REBOUND AFTER 63 Extends Tender Offer 63 Reaches Initial Resistance 63 Winning Streak Continues 63 Q3 Profit Declines 63 Q4 Profit Rises 63 Updates Guidance 63 Guides Q2 63 Announces Cash Dividend 63 Q2 Profit Rises 63 ISTA Pharmaceuticals 63 Discuss Third Quarter 63 VIA Pharmaceuticals 63 Q2 Profit Declines 63 Q4 Profit Declines 63 Announces Initiation 63 Sunesis Pharmaceuticals Inc. 63 SGEN 63 Completes Enrollment 63 % HIGHER 63 Shareholders Approve Merger 63 NASDAQ GILD 63 Sees Continued Upward Momentum 62 BMRN 62 Q1 Profit Rises 62 Announces Stock Repurchase